news
Cancer drug with accelerated approval fails Phase III trial
Results did not confirm the clinical benefit of Lartruvo in combination with doxorubicin compared to doxorubicin alone…
List view / Grid view
Anti-Cancer Therapeutics
news
European Commission approves prostate cancer treatment Erleada
Erleada (apalutamide) has been approved for non-metastatic castration-resistant prostate cancer patients who are at high risk of developing metastatic disease
news
Almac Group extends personalised cancer vaccine production facilities
The Almac Group, a CDMO serving the pharmaceutical and biotech sectors globally, is expanding its Edinburgh Technopole facility to allow scale-up of its personalised cancer vaccine activities...
news
Durvalumab improves survival of non-small cell lung cancer patients
Moffitt researchers conducted a Phase III trial which found durvalumab to increase the survival of patients with non-small cell lung cancer...
news
Pioneering radiotherapy machine treats its first patient in the UK
Improved accuracy and fewer patient side effects are among the benefits claimed for the pioneering radiotherapy machine...
news
New micro-platform improves understanding of cancer cells
A new low-cost, cell culture platform technique may provide insight for more effective cancer treatment, according to the researchers who developed it...
news
Cardiac monitoring for high-risk breast cancer patients ‘should be prioritised’
Cardiac monitoring of high-risk breast cancer patients should be prioritised, after research revealed low rates of heart monitoring seen in the patients receiving trastuzumab.
news
Senescent cells targeted with new nanocarrier drug delivery system
Senescent, or zombie cells, are being targeted with the development of a new nanocarrier drug delivery system.
news
Anti-PD-1 therapy linked to delayed onset of skin disease
The onset of side effects of a common cancer treatment, anti-PD-1 therapy can be identified up to 3 years after treatment...
news
Blood test predicts treatment response for metastatic prostate cancer
Testing could lead to extension of life through improved clinical decision-making by identifying patients who need to switch from targeted hormonal therapy to chemotherapy...
news
Phenformin-mTOR inhibitor combination shows promise in HCC
A combination of mTOR inhibitors and Phenformin leads to an increase in overall survival...
news
SMC approves Xermelo for carcinoid syndrome diarrhoea
Scotland is the first country in the UK to enable patients, battling this serious and debilitating condition, access to a new treatment option...
news
FDA accepts Larotrectinib New Drug Application and Grants Priority Review
The FDA has accepted the NDA and granted Priority Review for larotrectinib for advanced or metastatic solid tumours harbouring a NTRK gene fusion...
news
DNA-based vaccine treatment for colorectal cancer to undergo first human study
Researchers hope immunotherapy will prevent against overactive immune response...
news
Anticancer drug nintedanib found to be effective against malignant pleural mesothelioma
Researchers have found that nintedanib shows promising effectiveness in halting the growth of human malignant pleural mesothelioma in preclinical models.
